Patients With Alzheimer Disease Face a Disproportionate Drug Cost Burden
On average, patients with Alzheimer disease and related dementias spend $1199.70 per year on out-of-pocket prescription drug costs.
Related Articles
Leqembi: Side Effects No Worse in Clinical Use Than They Were in Trial | ALZFORUM
Lecanemab has been in clinical use in the U.S. for nearly two years, and in Japan for not quite a year. How is it going?…
Update on Noninvasive Neuromodulation Devices for Headache Treatment – Practical Neurology
Stewart J. Tepper, MD, Vice President of the New England Institute for Neurology and Headache, Peter McAllister, MD, FAAN, Chief Medical Officer of the New…
Microbial Load, Not Disease, Shapes Gut Microbiome Signatures – Neuroscience News
A new study reveals that changes in gut microbial load, influenced by factors like diet, age, and antibiotics, drive the presence of bacteria previously linked…
Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states
Psychedelics hold promise as alternate treatments for neuropsychiatric disorders. However, the neural mechanisms by which they drive adaptive behavioral effects remain unclear. We isolated the…
The Historical Case for a Strong and Diverse Neurology Clerkship Leadership Team | Neurology Education
The role of the clerkship director has evolved significantly over the past century and now requires a diverse range of skills to meet the rigorous…
Treatment of Unruptured Small and Medium‐Sized Wide Necked Aneurysms Using the 64‐Wire Surpass Evolve: A Subanalysis From the SEASE International Registry | Journal of the American Heart Association
BackgroundFlow diversion has revolutionized the management of wide‐necked intracranial aneurysms (IAs). We aimed to assess the effectiveness and safety of the new generation 64‐wire Surpass…
The Placebo Effect
Dr. Gregg Day talks with Dr. Kathryn T. Hall about the complexities of the placebo effect, its variability among patients, and the genetic factors that…
The Power of Delphi and Advocacy: Consensus in SCN8A-Related Epilepsy and Neurodevelopmental Disorders – Charuta Joshi, 2024
Original Article Citation: Global modified Delphi consensus on diagnosis, phenotypes, and treatment of SCN8A-related epilepsy and/or neurodevelopmental disorder…
Neurologic Care for Transgender and Gender-Diverse People | Neurology Clinical Practice
Purpose of ReviewTo summarize the literature on neurologic care for transgender and gender-diverse (TGD) people and provide implications for clinical practice.Recent FindingsThere are limited data…
Frontiers | Network-based statistics reveals an enhanced subnetwork in prefrontal cortex in mild cognitive impairment: a functional near-infrared spectroscopy study
1 Department of Neurological Rehabilitation, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, China 2 Beijing Key Laboratory of Rehabilitation Technical Aid s for Old-Age…
